Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alexandrina, Vlahova"'
Autor:
Desislava Kostova-Lefterova, Mariela Vasileva-Slaveva, Svilen Maslyankov, Assia Konsoulova, Margarita Atanasova, Tsvetelina Paycheva, Alexandrina Vlahova, Marusya Genadieva-Yordanova, Ginka Prodanova, Zahari Zahariev, Vasil Pavlov, Georgi Todorov, Boris Vasilev, Kostadin Angelov, Tashko Deliyski, Ivelina Petrova, Desislava Hitova, Ivo Petrov
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3932-3944 (2021)
(1) Background: We aimed to analyze currently available studies with intraoperative radiotherapy (IORT) as a choice of treatment where the Xoft Axxent® electronic brachytherapy (eBx) system was used as a single-dose irradiation and an exclusive radi
Externí odkaz:
https://doaj.org/article/de42e7803a764ac9985d15998c88ba45
Autor:
Ivo Petrov, Boris Vasilev, Tashko S. Deliyski, Ivelina U. Petrova, Assia Konsoulova, Ginka Prodanova, Mariela Vasileva-Slaveva, Marusya Genadieva-Yordanova, Alexandrina Vlahova, Angelov K, Vasil Pavlov, Georgi Todorov, Tsvetelina Paycheva, Desislava Hitova, Svilen Maslyankov, Margarita Atanasova, Desislava Kostova-Lefterova, Zahari Zahariev
Publikováno v:
Current Oncology, Vol 28, Iss 335, Pp 3932-3944 (2021)
Current Oncology
Current Oncology
(1) Background: We aimed to analyze currently available studies with intraoperative radiotherapy (IORT) as a choice of treatment where the Xoft Axxent® electronic brachytherapy (eBx) system was used as a single-dose irradiation and an exclusive radi
Autor:
Tsvetelina Spiridonova, Jordan Spirdonov, Slavyana Usheva, Theophil Sedloev, Alexandrina Vlahova, Mariela Vasileva-Slaveva
Publikováno v:
Anticancer Research. 39:4393-4398
Background/aim Metastatic breast cancer (MBC) represents a wide spectrum of heterogeneous conditions with different secondary spread sites, time to relapse and biology. MBC is still considered an incurable disease despite the fact that survival rates
Autor:
Theophil, Sedloev, Alexandrina, Vlahova, Slavyana, Usheva, Mariela, Vasileva-Slaveva, Tsvetelina, Spiridonova, Jordan, Spirdonov
Publikováno v:
Anticancer research. 39(8)
Metastatic breast cancer (MBC) represents a wide spectrum of heterogeneous conditions with different secondary spread sites, time to relapse and biology. MBC is still considered an incurable disease despite the fact that survival rates have improved
Autor:
R. Dodova, T. Dikov, Daniela Dacheva, M Taushanova – Hadjieva, Spartak Valev, Ivan Popov, Alexandrina Vlahova, Radka Kaneva, R. Tzveova, K Kamenarova, Konstanta Velinova Timcheva, Atanaska Mitkova, Vanio Ivanov Mitev, Svetlana Christova
Publikováno v:
Cancer Research. 76:P2-09
Background. Breast cancer is the most commonly diagnosed malignancy and the most frequent cause of death in women due to cancer. About 5% to 10% of breast cancers are thought to be hereditary. Pathogenic mutations in BRCA1/2 genes across Hereditary B
Publikováno v:
Bulgarian Review of Ophthalmology. 63:17
Introduction: Impression cytology is an alternative to excisional biopsy minimally invasive method of histological examination of the ocular surface. Aim: The purpose of this study was to determine changes in impression cytology samples of patients w
Autor:
Atanaska Mitkova, E. Popov, Ivan Popov, Vanio Mitev, Alexandrina Vlahova, Radka Kaneva, C. Slavov, T. Dikov, Darina Kachakova, Svetlana Christova
Publikováno v:
DNA and Cell Biology. 34:189-200
In the current study, expression levels of let-7c, miR-30c, miR-141, and miR-375 in plasma from 59 prostate cancer (PC) patients with different clinicopathological characteristics and two groups of controls: 16 benign prostatic hyperplasia (BPH) samp
Autor:
Theophil Sedloev, Spartak Valev, R. Dodova, Alexandrina Vlahova, Ivan Popov, Konstanta Velinova Timcheva, Atanas Stefanov Ionkov, Lina Basam Hadjo, Ivo Kremensky, Radka Kaneva, T. Dikov, Daniela Dacheva, Margarita Stoyanova Taushanova – Hadjieva, Stanislava Dimitrova Popova, Atanaska Mitkova, Vanio Ivanov Mitev, Marija Mitko Caulevska, Svetlana Christova
Publikováno v:
BMC Cancer
Background About 3885 women are diagnosed with breast cancer and 1285 die from the disease each year in Bulgaria. However no genetic testing to identify the mutations in high-risk families has been provided so far. Methods We evaluated 200 Bulgarian
Autor:
Angelov K, M.B. Vasileva, Svilen Maslyankov, G.T. Todorov, Z.I. Zahariev, Desislava Kostova-Lefterova, Assia Konsoulova, Tsvetelina Paycheva, V.M. Pavlov, Alexandrina Vlahova
Publikováno v:
Annals of Oncology. 30:iii41
Autor:
Lina Basam Hadjo, Radka Kaneva, Atanaska Mitkova, Marija Mitko Caulevska, Stanislava Dimitrova Popova, Atanas Stefanov Ionkov, Daniela Dacheva, Vanio Ivanov Mitev, Ivan Popov, Svetlana Christova, Alexandrina Vlahova, Margarita Stoyanova Taushanova – Hadjieva, Theophil Sedloev, Konstanta Velinova Timcheva, Ivo Kremensky, Spartak Valev, R. Dodova, T. Dikov
Publikováno v:
BMC Cancer
About 3885 women are diagnosed with breast cancer and 1285 die from the disease each year in Bulgaria. However no genetic testing to identify the mutations in high-risk families has been provided so far. We evaluated 200 Bulgarian women with primary